Of note, high levels of LDLR and low levels of IDOL (MYLIP) expression correlate with a worse prognosis in patients suffering from pancreatic cancer and other tumor entities (Figs 6G and S4C and D). This evidence concerns the gene LDLR and pancreatic neoplasm.